Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,248 | 119 | 53.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,700 | 2 | 46.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $2,338 | 7 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $2,141 | 12 | $0 (2021) |
| Abbott Laboratories | $896.83 | 37 | $0 (2022) |
| Forte Bio-Pharma LLC | $562.46 | 2 | $0 (2021) |
| Genentech USA, Inc. | $413.54 | 3 | $0 (2019) |
| SPR Therapeutics, Inc | $347.87 | 1 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $264.42 | 14 | $0 (2023) |
| Purdue Pharma L.P. | $124.19 | 9 | $0 (2018) |
| Allergan Inc. | $118.27 | 2 | $0 (2017) |
| Stimwave Technologies Incorporated | $115.23 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $201.12 | 10 | Collegium Pharmaceutical, Inc. ($123.15) |
| 2022 | $635.79 | 14 | SPR Therapeutics, Inc ($347.87) |
| 2021 | $559.64 | 21 | Abbott Laboratories ($510.38) |
| 2020 | $49.75 | 3 | SCILEX PHARMACEUTICALS INC. ($21.06) |
| 2019 | $632.37 | 20 | Genentech USA, Inc. ($277.04) |
| 2018 | $1,241 | 22 | Forte Bio-Pharma LLC ($544.70) |
| 2017 | $4,628 | 31 | PFIZER INC. ($2,172) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.64 | General |
| Category: Opioid Analgesic | ||||||
| 06/09/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.63 | General |
| Category: Opioid Analgesic | ||||||
| 05/11/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.66 | General |
| Category: Opioid Analgesic | ||||||
| 04/10/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: VACCINES | ||||||
| 04/07/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: Opioid Analgesic | ||||||
| 03/16/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Analgesic | ||||||
| 03/03/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.79 | General |
| Category: Opioid Analgesic | ||||||
| 01/31/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.84 | General |
| Category: Opioid Analgesic | ||||||
| 01/27/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $26.66 | General |
| 12/31/2022 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $347.87 | General |
| Category: Pain management | ||||||
| 11/22/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Pain Management | ||||||
| 11/10/2022 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Orthopedic | ||||||
| 11/03/2022 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.16 | General |
| Category: Opioid Analgesic | ||||||
| 10/27/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: PRIMARY CARE | ||||||
| 10/21/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $31.04 | General |
| Category: Neuromodulation | ||||||
| 10/12/2022 | Collegium Pharmaceutical, Inc. | ELYXYB - celecoxib (Drug) | Food and Beverage | Cash or cash equivalent | $19.85 | General |
| Category: Migraine | ||||||
| 09/29/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Pain Management | ||||||
| 06/09/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/20/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.36 | General |
| Category: Opioid Analgesic | ||||||
| 03/22/2022 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Pain Management | ||||||
| 03/03/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.29 | General |
| Category: Opioid Analgesic | ||||||
| 02/16/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Gastroenterology | ||||||
| 01/05/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Gastroenterology | ||||||
| 12/16/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $152.91 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 498 | 817 | $735,727 | $43,130 |
| 2022 | 19 | 610 | 871 | $899,143 | $56,812 |
| 2021 | 20 | 664 | 980 | $1.0M | $64,118 |
| 2020 | 19 | 652 | 953 | $775,973 | $54,774 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 115 | 219 | $58,019 | $10,703 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 83 | 114 | $41,482 | $8,037 | 19.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 19 | 24 | $87,130 | $4,042 | 4.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 29 | 40 | $89,533 | $2,970 | 3.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 21 | 30 | $111,257 | $2,936 | 2.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 32 | 37 | $156,201 | $2,757 | 1.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 20 | 20 | $11,623 | $1,837 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 31 | $8,772 | $1,821 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 20 | $8,110 | $1,658 | 20.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 20 | 28 | $59,551 | $1,565 | 2.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 23 | 23 | $11,076 | $1,322 | 11.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 18 | 22 | $44,997 | $1,136 | 2.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 26 | 30 | $20,964 | $1,086 | 5.2% |
| 20552 | Injection of trigger points, 1-2 muscles | Facility | 2023 | 20 | 34 | $20,489 | $937.33 | 4.6% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 16 | 16 | $6,383 | $308.40 | 4.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 129 | $140.00 | $12.50 | 8.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 134 | 255 | $48,000 | $12,867 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 82 | 122 | $34,411 | $9,023 | 26.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 51 | 67 | $127,551 | $5,045 | 4.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 48 | 48 | $22,453 | $4,894 | 21.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2022 | 48 | 63 | $151,219 | $4,779 | 3.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 17 | 23 | $83,139 | $4,019 | 4.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 27 | 41 | $148,460 | $3,979 | 2.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2022 | 27 | 40 | $86,828 | $2,313 | 2.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 18 | 19 | $38,078 | $1,689 | 4.4% |
About Dr. Jack Lam, MD
Dr. Jack Lam, MD is a Anesthesiology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1578721395.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Lam, MD has received a total of $7,948 in payments from pharmaceutical and medical device companies, with $201.12 received in 2023. These payments were reported across 121 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,248).
As a Medicare-enrolled provider, Lam has provided services to 2,424 Medicare beneficiaries, totaling 3,621 services with total Medicare billing of $218,835. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine
- Location Raleigh, NC
- Active Since 05/29/2008
- Last Updated 11/10/2025
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1578721395
Products in Payments
- EMBEDA (Drug) $2,170
- PRECISION (Device) $1,575
- Proclaim IPG (Device) $724.50
- Nalocet (Drug) $544.70
- GENERAL - PAIN MANAGEMENT (Device) $372.71
- SPRINT PNS System (Device) $347.87
- SPECTRA WAVEWRITER (Device) $175.00
- Belbuca (Drug) $123.67
- LINZESS (Drug) $104.38
- XTAMPZA (Drug) $96.16
- Proclaim Family of SCS IPGs (Device) $91.15
- mild Device Kit (Device) $89.19
- HYSINGLA ER (Drug) $60.57
- OXYCONTIN (Drug) $54.99
- Senza Spinal Cord Stimulation System (Device) $52.21
- Qutenza (Drug) $48.46
- RELISTOR (Drug) $42.65
- ZTLido (Drug) $40.22
- SCS IPGs (Device) $35.48
- PROCLAIM (Device) $31.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Raleigh
Gerald Maccioli, Md, MD
Anesthesiology — Payments: $329,678
Dr. Marc Yelle, Md Phd, MD PHD
Anesthesiology — Payments: $33,152
Dr. Paul Carnes, M.d, M.D
Anesthesiology — Payments: $16,641
Dr. Kevin Vorenkamp, M.d, M.D
Anesthesiology — Payments: $3,297
Robert Jacobson, Md, MD
Anesthesiology — Payments: $2,232
Duran Mitchell, M.d, M.D
Anesthesiology — Payments: $2,029